[1] |
Moreno, E. (2014). Retrospective and prospective perspectives on zoonotic brucellosis. Frontiers in Microbiology , 5(2): 213.
|
[2] |
Galińska, E. M., & Zagórski, J. (2013). Brucellosis in humans--etiology, diagnostics, clinical forms. Annals of Agricultural & Environmental Medicine Aaem , 20(2):233-238.
|
[3] |
景志刚, 严家瑞, 范伟兴. 布鲁氏菌病疫苗研究进展[J]. 中国人兽共患病学报, 2016, 32(2):188-199.JING Zhi-gang, YAN Jia-rui, FAN Wei-xing. (2016). Research progress of brucellosis vaccines [J]. Chinese Journal of Zoonoses , 32(2):188-199. (in Chinese)
|
[4] |
Cloeckaert, A., Grayon, M., Verger, J. M., Letesson, J. J., & Godfroid, F. (2000). Conservation of seven genes involved in the biosynthesis of the lipopolysaccharide o-side chain in brucella spp. Research in Microbiology , 151(3): 209-216.
|
[5] |
Dahouk, S. A., Neubauer, H., & Sprague, L. D. (2014). Brucella (B. abortus, B. melitensis, and B. suis) Sascha Al Dahouk, Heinrich Neubauer, and Lisa D. Sprague. Manual of Security Sensitive Microbes and Toxins .
|
[6] |
ENRIGHT, F.M. (1990): The Pathogenesis and pathobiology of Brucella infection in domesticanimals. Animal brucellosis , (55):301-320.
|
[7] |
Wang, Z., & Wu, Q. (2014). Research progress in live attenuated brucella vaccine development. Current Pharmaceutical Biotechnology , 14(10): 887.
|
[8] |
Lapaque, N., Moriyon, I. E., & Gorvel, J. (2005). Brucella lipopolysaccharide acts as a virulence factor. Current Opinion in Microbiology , 8(1): 60-66.
|
[9] |
Godfroid, F., Cloeckaert, A., Taminiau, B., Danese, I., Tibor, A., & Bolle, X. D., et al. (2000). Genetic organisation of the lipopolysaccharide o-antigen biosynthesis region of brucella melitensis, 16m ( wbk ). Research in Microbiology , 151(8): 655-668.
|
[10] |
易德武.羊种布鲁氏菌015株gmd、per和manb缺失株的构建及诊断抗原反应原性评价研究[D]. 石河子:石河子大学, 2015.YI De-wu. (2015). Research on Construlction and Immunogenicity of gmd, per and manb Mutant Strains of Burcella Melitensis 015 [D]. Master Thesis. Shihezi University, Shihezi. (in Chinese)
|
[11] |
Oliveira, S. C., Giambartolomei, G. H., & Cassataro, J. (2011). Confronting the barriers to develop novel vaccines against brucellosis. Expert Review of Vaccines , 10(9): 1,291-1,305.
|